anti-Influenza A antibody product blog
Tags: Antibody; Polyclonal Antibody; INFLUENZA A; anti-INFLUENZA A antibody;
The Influenza A n/a (Catalog #MBS534329) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. The Influenza An antibody (H1N1) (HRP) reacts with Influenza An and may cross-react with other species as described in the data sheet. MyBioSource\'s Influenza A can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunohistochemistry (IHC), Western Blot (WB). Researchers should empirically determine the suitability of the Influenza A n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Goat polyclonal Influenza An antibody (H1N1) (HRP) conjugated.
Biological Significance: Influenza A (H1N1) virus is a subtype of influenza A virus and was the most common cause of human influenza (flu) in 2009. Some strains of H1N1 are endemic in humans and cause a small fraction of all influenza-like illness and a small fraction of all seasonal influenza. H1N1 strains caused a few percent of all human flu infections in 2004?2005. Tag/Conjugate: HRP
Immunogen: Influenza An antibody (H1N1) (HRP) was raised in goat using Influenza A, strain USSR (H1N1) as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Influenza An are readily searchable from our website. Different antibodies against the same target such as Influenza A may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.